Pay in 4 interest-free payments of $6.62 Learn more
Ships within 48 hours · Estimated delivery Nov 15 - Nov 20
5a, b and Fig
[1] Mechanistically it works along a single hormonal pathway the amylin system which is what distinguishes it from the multi-receptor incretin agonists it is often compared with
PMID: 34367949
Clinical Effectiveness: SURMOUNT-1 Trial (Tirzepatide 15 mg): Duration: 72 weeks Participants: 2,539 adults with obesity Average Weight Loss: 22.5% of body weight 10 mg Dose: 21.4% weight loss 5 mg Dose: 15.0% weight loss Placebo: 2.4% weight loss 5% Weight Loss: 96% of participants 10% Weight Loss: 89% of participants 15% Weight Loss: 78% of participants 20% Weight Loss: 63% of participants This is the best weight loss result ever achieved with medication in clinical trials
50% *RI
